The potential of blood-based biomarkers to stratify patient risk of developing hemorrhagic stroke

Maria Alonso De Leciñana, MD, PhD, La Paz University Hospital, Madrid, Spain, discusses the potential of blood-based biomarkers to stratify patient risk of developing hemorrhagic stroke, particularly in the context of cerebral microbleeds and small vessel disease. Dr Leciñana highlights biomarkers that can be used to predict stroke risk and prognosis. However, she notes that these biomarkers are not yet widely implemented in clinical practice and require further validation in clinical trials. This interview took place at the 11th European Stroke Organisation Conference (ESOC) in Helsinki, Finland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Видео The potential of blood-based biomarkers to stratify patient risk of developing hemorrhagic stroke канала VJNeurology